amlodipine has been researched along with perindopril in 188 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 6 (3.19) | 18.2507 |
| 2000's | 40 (21.28) | 29.6817 |
| 2010's | 114 (60.64) | 24.3611 |
| 2020's | 28 (14.89) | 2.80 |
| Authors | Studies |
|---|---|
| González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Sun, H | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Lamote, J; Sennesael, J; Tasse, S; Verbeelen, D; Violet, I | 1 |
| Lamote, JG; Sennesael, JJ; Tasse, S; Verbeelen, DL; Violet, I | 1 |
| Bennett, MA; Hillier, C; Thurston, H | 1 |
| Berman, K; Campbell, DJ; Monaghan, JC; Ryan, M; Stokes, GS | 1 |
| Bernaud, CM; Fay, R; Zannad, F | 1 |
| Donnan, PT; Lim, PO; MacDonald, TM | 1 |
| Iwao, H; Izumi, Y; Kim, S; Zhan, Y | 1 |
| Chen, D; Lin, J; Wu, K | 1 |
| Jeffery, TK; Wanstall, JC | 1 |
| Beevers, G; Caulfield, M; Collins, R; Dahlöf, B; Kjeldsen, SE; McInnes, GT; Mehlsen, J; Nieminen, M; O'Brien, E; Ostergren, J; Poulter, NR; Sever, PS; Wedel, H | 1 |
| Peuhkurinen, K; Risteli, J; Ruskoaho, H; Tokola, H; Uusimaa, P; Vuolteenaho, O; Ylitalo, A | 1 |
| Beevers, DG; Blann, AD; Gurney, D; Lip, GY; Spencer, CG | 1 |
| Candy, GP; Essop, MR; Hlatshwayo, NM; Kachope, J; Libhaber, CD; Libhaber, EN; Norton, GR; Puane, MO; Sareli, P; Sliwa, K; Woodiwiss, AJ | 1 |
| Kulschewski, A; Schrader, J | 1 |
| Baykal, B; Baysan, O; Cincik, M; Kayir, H; Ozkan, M; Ozogul, C; Sag, C; Uzbay, IT; Uzun, M; Yokusoglu, M | 1 |
| Karpov, IuA | 1 |
| Füessl, HS | 1 |
| Collier, D; Cruickshank, K; Hughes, AD; Lacy, PS; O'Rourke, M; Stanton, A; Thom, SM; Thurston, H; Williams, B | 1 |
| Fournier, A; Safar, ME | 1 |
| De la Figuera von Wichmann, M; Llisterri Caro, JL | 1 |
| Chiara Cavallini, M; Palmieri, V; Pini, R | 1 |
| Blann, AD; Felmeden, DC; Lip, GY; Spencer, CG | 1 |
| Czupryniak, L; Loba, J; Pawłowski, M; Saryusz-Wolska, M | 1 |
| Rahn, KH | 1 |
| Dahlof, B; Dobson, J; Gupta, AK; Poulter, NR; Sever, PS; Wedel, H | 1 |
| Cao, G; Mastai, R; Mella, J; Muñoz, MC; Pereyra, L; Toblli, JE | 1 |
| Baykal, B; Baysan, O; Cincik, M; Kayir, H; Koz, C; Ozkan, M; Ozogul, C; Sag, C; Uzbay, IT; Uzun, M; Yokusoglu, M | 1 |
| Hedner, T; Kjeldsen, SE; Narkiewicz, K; Oparil, S | 1 |
| Mourad, JJ; Waeber, B | 1 |
| Mehlsen, J | 1 |
| Bendersky, M; Ferdinand, KC; Forcada, P; Grassi, D; Kotliar, C; O'Flaherty, M; Pellizzari, M; Rodriguez, P; Turri, D | 1 |
| Beevers, G; Caulfield, M; Collins, R; Dahlöf, B; Kjeldsen, SE; Kristinsson, A; McInnes, GT; Mehlsen, J; Nieminen, M; O'Brien, E; Ostergren, J; Poulter, NR; Sever, PS; Wedel, H | 1 |
| Aota, Y; Iwasaka, T; Maki, K; Morimoto, S; Sakuma, T | 1 |
| Ferrari, R | 1 |
| Chang, CL; Dahlof, B; Mastorantonakis, S; Poulter, NR; Sever, PS; Wedel, H | 1 |
| Widimský, J | 1 |
| Bahl, VK; Jadhav, UM; Thacker, HP | 1 |
| Krzesinski, JM; Scheen, AJ | 1 |
| Atkins, N; Caulfield, M; Collier, D; Dicker, P; Dolan, E; McInnes, G; O'Brien, E; Stanton, AV; Thom, S | 1 |
| Campbell, NR; Dahlöf, B; Dobson, JE; Poulter, NR; Sever, PS; Wedel, H | 1 |
| Cheng, XM; Chu, WW; Du, M; Li, Y; Ma, SM | 1 |
| Gaudouen, Y; Le Jeune, S; Lopez-Sublet, M; Mourad, C; Mourad, JJ; Pirollo, A | 1 |
| Cappuccio, FP; Caulfield, M; Collier, D; Cruickshank, JK; Dobson, J; Eldridge, S; Feder, G; Gupta, AK; Poulter, NR; Sever, PS | 1 |
| Bălan, H | 1 |
| Ruilope, LM; Schaefer, A | 1 |
| Ghiadoni, L | 1 |
| Nedogoda, SV | 1 |
| Chang, CL; Dahlöf, B; Gupta, AK; Nasothimiou, EG; Poulter, NR; Sever, PS | 1 |
| Avksent'eva, MV; Mal'chikova, SV; Tarlovskaia, EI | 1 |
| Ishmurzin, GP | 1 |
| Poulter, NR | 1 |
| Mourad, JJ | 1 |
| Deev, AD; Karpov, IuA | 1 |
| Belenkov, IuN; Danilogorskaia, IuA; Privalova, EV; Shchendrygina, AA; Zheleznykh, EA | 1 |
| Hatala, R; Hatalová, K; Pella, D; Šidlo, R | 2 |
| Doros, A; Fekete, A; Langer, RM; Rudolf, A; Wagner, L | 1 |
| Abbas, SS; El-Bardicy, MG; Essam, HA; Zaazaa, HE | 1 |
| Spence, JD | 1 |
| Nagy, VL | 1 |
| Budagovskaya, ZM; Iskenderov, BG; Sisina, ON | 1 |
| Kobalava, ZhD; Kotovskaia, IuV; Luk'ianova, EA | 1 |
| Baksi, AJ; Barron, AJ; Fitzgerald, D; Hughes, AD; Jabbour, RJ; Mayet, J; O'Brien, E; Poulter, N; Sever, P; Sharp, A; Stanton, A; Surendran, P; Thom, S | 1 |
| Ruilope, L; Schaefer, A | 1 |
| Sharma, K; Sweiss, N | 1 |
| Tóth, K | 1 |
| Dmitrova, TB; Kobalava, ZhD; Kotovskaia, IuV; Luk'ianova, EA; Troitskaia, EA | 1 |
| Ruilope, L | 1 |
| Páll, D; Szabó, Z; Szántó, I | 1 |
| Amodeo, C; Asmar, R; Chazova, IE; Gamba, MA; Mancia, G; Mourad, JJ; Puig, JG; Taddei, S | 1 |
| Chazova, I; Erglis, A; Farsang, C; Laucevicius, A; Laurent, S; Parati, G; Sirenko, Y | 1 |
| Angeloni, E; Lombardo, P; Pirelli, M; Refice, S; Vitaterna, A | 1 |
| Borghi, C; Cicero, AF; Morbini, M | 1 |
| Budagovskaia, ZM; Iskenderov, BG; Sisina, ON | 1 |
| Krzesinski, JM; Lancellotti, P; Scheen, AJ | 1 |
| Khashieva, FM; Poteshkina, NG | 1 |
| Bakris, GL; Elliott, WJ; Feldstein, JD; Whitmore, J | 1 |
| Elliott, WJ | 2 |
| Kobalava, ZD; Kotovskaya, YV; Tigai, ZG; Villevalde, SV | 1 |
| Kizilirmak, P; Ongen, Z | 1 |
| Mancia, G | 1 |
| Khodorovich, NA; Kobalava, ZD; Kotovskaya, YV | 1 |
| Abbas, SS; Essam, HM; Hegazy, MA; Zaazaa, HE | 1 |
| Abo-Talib, NF; El-Ghobashy, MR; Saad, AS | 1 |
| Grammatikou, V; Kallistratos, M; Manolis, A; Tsioufis, K; Zarifis, J | 1 |
| Khodorovich, NA; Kobalava, ZhD; Kotovskaia, IuV | 1 |
| McCormack, PL; Shirley, M | 1 |
| Deev, AD; Gorbunov, VM; Karpov, YA | 1 |
| Chen, X; Hu, P; Jiang, J; Liu, T; Zheng, X | 1 |
| Ruilope, LM | 1 |
| Ferguson, K; Klibanov, OM; Phan, D | 1 |
| Borovkova, NY; Kuznetsova, TE | 1 |
| Borovkov, NN; Borovkova, NJ; Kovaleva, GV; Kuznecova, TE | 1 |
| Hu, D; Huang, J; Liao, Y; Sun, Y; Yang, K; Zhao, R | 1 |
| Abdelhady, A; Albow, A; Khader, S; Sinnuqrut, S | 1 |
| Pichler, G; Redon, J | 2 |
| Häckel, A | 1 |
| Einecke, D | 1 |
| Filippov, EV; Yakushin, SS | 1 |
| Grammatikou, V; Kallistratos, M; Karagiannis, A; Vlachopoulos, C | 1 |
| Bertrand, ME; Mourad, JJ; Vlachopoulos, C | 1 |
| Dézsi, CA; Nádházi, Z | 1 |
| Ahmed, M; Al-Wahshi, Y; Al-Zakwani, I; Alanbaei, M; El Tamimi, H | 1 |
| Dézsi, CA; Forster, T | 1 |
| Bicknell, C; Falaschetti, E; Kiru, G; Poulter, N; Powell, J | 1 |
| Radchenko, G; Sirenko, Y | 1 |
| Attallah, MA; El-Bagary, RI; Elkady, EF; Mowaka, S | 1 |
| Al-Sharea, A; Dart, AM; Du, XJ; Gao, XM; Han, LP; Kiriazis, H; Moore, S; Murphy, AJ; Su, Y; Tsai, A | 1 |
| Gilyarevskiy, SR | 1 |
| Ostroumova, OD | 1 |
| Glezer On Behalf Of Program Participants, MG | 1 |
| Dell'Avvocata, F; Lenti, S; Mazza, A; Ramazzina, E; Rigatelli, G; Sacco, AP; Schiavon, L | 1 |
| Amodeo, C; Asmar, R; Brzozowska-Villatte, R; de Champvallins, M; Mourad, JJ | 1 |
| Amar, L; Barigou, M; Calvet, D; Dominiczak, AF; Guzik, T; Jennings, G; Laurent, S; Rossi, GP; Touyz, RM; Turc, G | 1 |
| Kotsis, VT; Liakos, CI; Papadopoulos, DP | 1 |
| Ábrahám, G; Dézsi, CA | 1 |
| Bridgeman, MB; Dalal, KS | 1 |
| Ezhova, N; Kobalava, Z; Troitskaya, E | 1 |
| Chumachek, EV; Judina, JS; Khripaeva, VJ; Konradi, AO; Ledyaeva, AA; Nedogoda, SV; Palashkin, RV; Salasyuk, AS; Smirnova, VO; Tsoma, VV; Zvartau, NE | 1 |
| Chung, E; Ortiz, M; Simons, LA | 1 |
| Kundzina, L; Lejniece, S | 1 |
| Ferenci, T; Finta, E; Gasparics, R; Medvegy, M; Simonyi, G | 1 |
| Radermecker, RP | 1 |
| Bistrika, EA; Elliott, WJ | 1 |
| Borisova, EV; Ostroumova, OD; Pavleeva, EE | 1 |
| Borghi, C; Buda, S; Degli Esposti, L; Gambera, M; Nati, G; Perone, F; Perrone, V; Tagliabue, PF; Veronesi, C | 1 |
| Borisova, EV; Kochetkov, AI; Ostroumova, OD; Ostroumova, TM | 1 |
| Fleig, SV; Haller, H; Limbourg, FP; Weger, B | 1 |
| Dézsi, CA | 1 |
| Bezuglova, EI; Kornilov, AA; Luneva, YV; Povetkin, SV | 1 |
| Aje, A; Badri, M; Barasa, F; Damasceno, A; Dzudie, A; Francis, V; Jones, E; Kana, SS; Kramer, N; Mayosi, BM; Mntla, P; Mondo, C; Ogah, O; Ogola, EN; Ogunbanjo, G; Ojji, DB; Okpechi, I; Poulter, N; Sani, MU; Shedul, G; Sliwa, K; Smythe, W | 1 |
| Statsenko, ME; Titarenko, MN; Turkina, SV | 1 |
| Laurent, S; Mancia, G; Poulter, N | 1 |
| Ramirez, AJ; Sanchez, MJ; Sanchez, RA | 1 |
| Borisova, EV; Guseva, TF; Ostroumova, OD; Temirbulatov, II | 1 |
| Kobalava, ZD; Tolkacheva, VV; Troitskaya, EA | 1 |
| Abd El-Fattah, AI; Eltablawy, NA; Rashed, LA; Zaghloul, MS | 1 |
| Lishuta, AS; Privalova, EV | 1 |
| Drobotya, NV; Guseynova, ES; Morgunov, MN; Torosyan, SS | 1 |
| Douma, S; Kallistratos, MS; Manolis, AJ; Tsioufis, K | 1 |
| Badri, M; Barasa, F; Cornelius, V; Damasceno, A; Dzudie, A; Francis, V; Jones, E; Kramer, N; Mayosi, B; Mondo, C; Ogah, O; Ogola, E; Ojji, DB; Okpechi, IG; Poulter, N; Rayner, B; Sani, MU; Shedul, G; Shedul, GL; Sliwa, K; Smythe, W | 1 |
| Dolan, E; Gupta, AK; O'Brien, E; Poulter, NR; Sever, PS; Whitehouse, A | 1 |
| van der Merwe, WM | 1 |
| Dehayem, MY; Etoa, M; Hamadou, B; Kaze, FF; Kengne, AP; Kouam, M; Mbanya, JC; Mfeukeu-Kuate, L; Nganou-Gnindjio, CN; Ngassam, E; Nkamgna, A; Sobngwi, E; Tankeu, AT | 1 |
| Dézsi, CA; Simon, A | 1 |
| Brown, K; Donato, A | 1 |
| Asmar, R; De Champvallins, M; Feldmann, L; Mourad, JJ; Topouchian, J | 2 |
| Degli Esposti, L; Gambera, M; Nati, G; Perone, F; Perrone, V; Tagliabue, PF; Veronesi, C; Volpe, M | 1 |
| Glezer, MG | 1 |
| Onakpoya, I | 1 |
| Lenti, S; Mazza, A; Rigatelli, G; Rossetti, C; Rubello, D; Schiavon, L; Torin, G; Townsend, DM | 1 |
| Tůmová, E; Vrablík, M | 1 |
| Argyris, AA; Protogerou, AD; Samara, S | 1 |
| Fendrikova, AV; Gutova, SR; Skibitskiy, AV; Skibitskiy, VV | 1 |
| Begrambekova, YL; Levin, AM; Mareev, VY; Minina, YV | 1 |
| Chaudhary, G; Joseph, S; Konda Reddy, KM; Murthy, LS; Nikam, P; Rajarshi, M; Sawhney, JP; Shah, S; Thacker, H | 1 |
| Moskaleva, PV; Nasyrova, RF; Petrova, MM; Shnayder, NA | 1 |
| Badr, KA; Rezk, MR | 1 |
| Ancion, A; Lancellotti, P; Scheen, AJ | 1 |
| Arablincky, NA; Kirichenko, AA; Kochetkov, AI; Ostroumova, OD; Romanovsky, RR; Shatalova, NA | 1 |
| Barbashina, TA; Gavriljuk, EV; Mal, GS; Pribylov, CA; Pribylov, VS; Pribylova, NN; Yakovleva, MV | 1 |
| Aje, A; Albertino, D; Barasa, F; Dzudie, A; Francis, V; Hickman, N; Ingabire, PM; Jones, ESW; Mondo, C; Ogah, OS; Ogola, E; Ojji, DB; Rayner, B; Sani, M; Shahiemah, P; Shedul, G; Shedul, GL; Sliwa, K; Smythe, W; Stewart, S | 1 |
| Goreva, LA; Karapetyan, LV; Kobalava, ZD; Kolesnik, EL; Shavarova, EK | 1 |
| Syed, YY | 1 |
| Abdelsattar, AT; Cherfaoui, O; Elmoursi, A; Farhat, AM; Habboush, S; Masoud, AT; Sofy, AA | 1 |
| Ackbarkhan, A; Mbanya, A; Mbanya, JC; Mittoo, MY; Ramamonjisoa, HA; Ramilitiana, B; Ranivoharisoa, EM; Ratsimbazafy, SJN | 1 |
| Kasagić-Vujanović, I; Mandić-Kovačević, N; Popović Bijelić, A | 1 |
| Borghi, C; Cicero, AFG; D'Addato, S; Fogacci, F; Giovannini, M; Rizzoli, E | 1 |
| Barasa, F; Cornelius, V; Damasceno, A; Dzudie, A; Francis, V; Hickman, N; Ingabire, PM; Jones, E; Mondo, C; Ogah, O; Ogola, E; Ojji, DB; Pandie, S; Partington, G; Poulter, N; Rayner, B; Sani, MU; Shedul, G; Shedul, GL; Sliwa, K; Smythe, W | 1 |
| Elmoursi, A; Kamel, IS; Kassem, A; Khalil, F; Mancy, IME; Mohamed, SED; Mostafa, S; Ramadan, IG; Shabana, H; Zedan, HA | 1 |
| Fares, NV; Farouk, M; Hemdan, A; Magdy, R | 1 |
| Borghi, C; Bortolotto, LA; Degli Esposti, L; Jayagopal, PB; Konradi, A; Perrone, V; Snyman, JR | 1 |
| Abdelaziz, A; Badr El-Din, KM; Derayea, S; Nagy, DM; Salem, H | 1 |
| Tchernev, G | 2 |
| Souček, M | 1 |
| Borghi, C; Bortolotto, LA; Degli Esposti, L; Jayagopal, PB; Konradi, AO; Perrone, V; Snyman, JR | 1 |
24 review(s) available for amlodipine and perindopril
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
[Old or new antihypertensives--which are better?].
Topics: Adrenergic beta-Antagonists; Amlodipine; Angiotensin I; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Atenolol; Bendroflumethiazide; Calcium Channel Blockers; Clinical Trials as Topic; Diuretics; Drug Therapy, Combination; Humans; Hypertension; Perindopril; Risk; Risk Factors; Sodium Chloride Symporter Inhibitors; Time Factors | 2005 |
[Ischemic heart disease combined with hypertension: peculiarities of course and selection of therapy].
Topics: Adrenergic beta-Antagonists; Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Atenolol; Calcium Channel Blockers; Controlled Clinical Trials as Topic; Enalapril; Female; Humans; Hypertension; Indoles; Male; Middle Aged; Myocardial Ischemia; Nifedipine; Perindopril; Placebos; Risk Factors; Surveys and Questionnaires; Time Factors; Vasodilator Agents; Verapamil | 2005 |
[Overview of cardiovascular risk factors].
Topics: Age Factors; Aged; Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Aspirin; Calcium Channel Blockers; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Double-Blind Method; Drug Therapy, Combination; Europe; Female; Humans; Hyperlipidemias; Hypertension; Hypolipidemic Agents; Male; Meta-Analysis as Topic; Perindopril; Platelet Aggregation Inhibitors; Primary Prevention; Prospective Studies; Randomized Controlled Trials as Topic; Risk Factors; Sex Factors; Smoking Prevention; Spain; Vasodilator Agents | 2006 |
Optimizing the treatment of hypertension and stable coronary artery disease: clinical evidence for fixed-combination perindopril/amlodipine.
Topics: Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Calcium Channel Blockers; Clinical Trials as Topic; Coronary Artery Disease; Drug Combinations; Female; Humans; Hypertension; Male; Perindopril; Practice Guidelines as Topic | 2008 |
[The combination of an ACE inhibitor and a calcium channel blocker is an optimal combination for the treatment of hypertension].
Topics: Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Calcium Channel Blockers; Cardiovascular Diseases; Drug Combinations; Humans; Hypertension; Perindopril | 2009 |
Combinations of inhibitors of the renin-angiotensin system with calcium channel blockers for the treatment of hypertension: focus on perindopril/amlodipine.
Topics: Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Calcium Channel Blockers; Drug Therapy, Combination; Humans; Hypertension; Perindopril; Renin-Angiotensin System; Treatment Outcome | 2010 |
Perindopril for the treatment of hypertension.
Topics: Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Cardiovascular Diseases; Dose-Response Relationship, Drug; Drug Combinations; Humans; Hypertension; Indapamide; Perindopril | 2011 |
Which patients benefit the most from the perindopril/amlodipine combination.
Topics: Amlodipine; Antihypertensive Agents; Clinical Trials as Topic; Coronary Artery Disease; Humans; Hypertension; Perindopril | 2011 |
[Remodeling of vascular bed in patients with arterial hypertension: possibilities of diagnostics and correction].
Topics: Aged; Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Biological Availability; Blood Vessels; Calcium Channel Blockers; Drug Combinations; Drug Synergism; Humans; Hypertension; Male; Microcirculation; Perindopril; Secondary Prevention; Treatment Outcome | 2012 |
Adiponectin effects on the kidney.
Topics: Adiponectin; Albuminuria; Amlodipine; AMP-Activated Protein Kinases; Animals; Benzimidazoles; Benzoates; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Disease Progression; Humans; Kidney; Kidney Diseases; Mice; Obesity; Oxidative Stress; Perindopril; Renal Insufficiency, Chronic; Telmisartan | 2014 |
Combination therapy in the extended cardiovascular continuum: a focus on perindopril and amlodipine.
Topics: Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Calcium Channel Blockers; Cardiovascular Diseases; Disease Progression; Drug Combinations; Humans; Hypertension; Perindopril | 2015 |
Rationale for a single-pill combination of perindopril arginine and amlodipine besylate.
Topics: Amlodipine; Antihypertensive Agents; Cardiovascular Diseases; Clinical Trials as Topic; Drug Combinations; Humans; Perindopril | 2015 |
Prestalia--another combination for hypertension.
Topics: Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Calcium Channel Blockers; Clinical Trials as Topic; Drug Combinations; Humans; Hypertension; Perindopril | 2015 |
Perindopril/amlodipine (Prestalia(®)): a review in hypertension.
Topics: Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Drug Combinations; Drug Interactions; Humans; Hypertension; Perindopril; Randomized Controlled Trials as Topic | 2015 |
Triple Combination Therapy for Global Cardiovascular Risk: Atorvastatin, Perindopril, and Amlodipine.
Topics: Amlodipine; Anticholesteremic Agents; Antihypertensive Agents; Atorvastatin; Calcium Channel Blockers; Cardiovascular Diseases; Combined Modality Therapy; Humans; Perindopril; Risk Factors | 2016 |
The Results of ACES (Antihypertensive Combinations' Long Term Efficacy Comparing Study): Analysis of Metabolic Effects of Antihypertensive Combination Therapies.
Topics: Adult; Aged; Aged, 80 and over; Amlodipine; Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Carbazoles; Carvedilol; Diuretics; Drug Combinations; Essential Hypertension; Female; Humans; Hypertension; Indapamide; Lipoproteins, LDL; Male; Middle Aged; Perindopril; Propanolamines; Prospective Studies; Risk Factors | 2016 |
[The Role of the Three-Drug Combination Antihypertensive in Improving the Treatment of Arterial Hypertension].
Topics: Amlodipine; Antihypertensive Agents; Drug Therapy, Combination; Humans; Hypertension; Indapamide; Perindopril | 2017 |
[Fixed-Drug Combination Amlodipine, Indapamide and Perindopril: New Horizons of Antihypertensive Therapy].
Topics: Amlodipine; Antihypertensive Agents; Blood Pressure; Drug Combinations; Drug Therapy, Combination; Drug-Related Side Effects and Adverse Reactions; Humans; Hypertension; Indapamide; Perindopril | 2017 |
[Lipertance® The ASCOT single-pill combination has finally arrived].
Topics: Amlodipine; Atorvastatin; Cardiovascular Diseases; Clinical Trials as Topic; Drug Combinations; Humans; Hypertension; Perindopril; Risk Factors | 2017 |
Perindopril arginine and amlodipine besylate for hypertension: a safety evaluation.
Topics: Amlodipine; Antihypertensive Agents; Blood Pressure; Cough; Dose-Response Relationship, Drug; Drug Combinations; Edema; Humans; Hypertension; Perindopril | 2018 |
Perindopril/Indapamide/Amlodipine in Hypertension: A Profile of Its Use.
Topics: Amlodipine; Antihypertensive Agents; Blood Pressure; Drug Combinations; Humans; Hypertension; Indapamide; Perindopril; Prospective Studies; Quality of Life; Randomized Controlled Trials as Topic | 2022 |
Efficacy of Single-Pill, Triple Antihypertensive Therapy in Patients with Uncontrolled Hypertension: A Systematic Review and Meta-analysis.
Topics: Adult; Amlodipine; Antihypertensive Agents; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Drug Combinations; Humans; Hypertension; Indapamide; Perindopril | 2022 |
Evaluation of the Safety and Efficacy of Dual Therapy Perindopril/Amlodipine in the Management of Hypertension. A Systematic Review and Meta-Analysis.
Topics: Amlodipine; Antihypertensive Agents; Blood Pressure; Drug Combinations; Humans; Hypertension; Perindopril; Treatment Outcome | 2022 |
50 trial(s) available for amlodipine and perindopril
| Article | Year |
|---|---|
Comparison of perindopril and amlodipine in cyclosporine-treated renal allograft recipients.
Topics: Adult; Aged; Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Cross-Over Studies; Cyclosporine; Double-Blind Method; Female; Hemodynamics; Humans; Hypertension; Indoles; Kidney; Kidney Transplantation; Male; Middle Aged; Perindopril; Transplantation, Homologous | 1995 |
Divergent effects of calcium channel and angiotensin converting enzyme blockade on glomerulotubular function in cyclosporine-treated renal allograft recipients.
Topics: Adult; Aged; Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Cross-Over Studies; Cyclosporine; Double-Blind Method; Female; Glomerular Filtration Rate; Humans; Immunosuppressive Agents; Indoles; Kidney Glomerulus; Kidney Transplantation; Kidney Tubules; Lithium; Male; Middle Aged; Perindopril; Placebos; Renal Plasma Flow, Effective; Sodium; Transplantation, Homologous; Uric Acid; Vascular Resistance | 1996 |
Double-blind crossover study of the interaction between perindopril and amlodipine on blood pressure and hormones related to fluid and electrolyte balance in patients with essential hypertension.
Topics: Adult; Aged; Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Calcium Channel Blockers; Cross-Over Studies; Double-Blind Method; Drug Therapy, Combination; Female; Hormones; Humans; Hypertension; Indoles; Male; Middle Aged; Perindopril; Water-Electrolyte Balance | 1998 |
Double-blind, randomized, multicentre comparison of the effects of amlodipine and perindopril on 24 h therapeutic coverage and beyond in patients with mild to moderate hypertension. General Physicians Investigators' Group.
Topics: Adolescent; Adult; Aged; Amlodipine; Antihypertensive Agents; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Circadian Rhythm; Double-Blind Method; Female; Follow-Up Studies; Humans; Hypertension; Indoles; Male; Middle Aged; Perindopril; Prognosis; Safety | 1999 |
Does the Dundee Step Test predict outcome in treated hypertension? A sub-study protocol for the ASCOT trial. Anglo-Scandinavian Cardiac Outcome Trial.
Topics: Adult; Aged; Amlodipine; Antihypertensive Agents; Atenolol; Bendroflumethiazide; Blood Pressure; Diuretics; Drug Therapy, Combination; Electrocardiography; Exercise Test; Female; Humans; Hypertension; Incidence; Male; Middle Aged; Perindopril; Predictive Value of Tests; Survival Rate; Treatment Outcome | 2000 |
[The effect of amlodipine, nifedipine and perindopril on insulin sensitivity and blood lipid of patients with essential hypertension].
Topics: Amlodipine; Antihypertensive Agents; Calcium Channel Blockers; Female; Humans; Hypertension; Insulin Resistance; Lipids; Male; Middle Aged; Nifedipine; Perindopril | 1998 |
Von Willebrand factor, soluble P-selectin, and target organ damage in hypertension: a substudy of the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT).
Topics: Adult; Aged; Amlodipine; Antihypertensive Agents; Atenolol; Bendroflumethiazide; Blood Pressure; Cross-Sectional Studies; Electrocardiography; Female; Hematocrit; Hemorheology; Humans; Hypertension; Hypertrophy, Left Ventricular; Male; Middle Aged; P-Selectin; Perindopril; Regression Analysis; Single-Blind Method; Treatment Outcome; von Willebrand Factor | 2002 |
Effect of slow-release indapamide and perindopril compared with amlodipine on 24-hour blood pressure and left ventricular mass in hypertensive patients of African ancestry.
Topics: Adult; Aged; Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Black People; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Calcium Channel Blockers; Circadian Rhythm; Diastole; Diuretics; Female; Humans; Hypertension; Hypertrophy, Left Ventricular; Indapamide; Male; Middle Aged; Perindopril; Prospective Studies; South Africa; Systole; Time Factors; Treatment Outcome | 2004 |
Differential impact of blood pressure-lowering drugs on central aortic pressure and clinical outcomes: principal results of the Conduit Artery Function Evaluation (CAFE) study.
Topics: Age Distribution; Amlodipine; Antihypertensive Agents; Aorta; Atenolol; Blood Pressure; Brachial Artery; Cardiovascular Diseases; Drug Therapy, Combination; Female; Humans; Hypertension; Male; Middle Aged; Perindopril; Renal Insufficiency; Sodium Chloride Symporter Inhibitors; Treatment Outcome | 2006 |
Effects of "newer" and "older" antihypertensive drugs on hemorrheological, platelet, and endothelial factors. A substudy of the Anglo-Scandinavian Cardiac Outcomes Trial.
Topics: Adrenergic beta-Antagonists; Aged; Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Atenolol; Bendroflumethiazide; Blood Flow Velocity; Blood Pressure; Calcium Channel Blockers; Diuretics; Endothelium, Vascular; Female; Humans; Hypertension; Male; Middle Aged; P-Selectin; Perindopril; Platelet Activation; United Kingdom; Vascular Resistance; von Willebrand Factor | 2007 |
Circadian blood pressure variation and antihypertensive medication adjustment in normoalbuminuric type 2 diabetes patients.
Topics: Adult; Aged; Amlodipine; Antihypertensive Agents; Bisoprolol; Blood Pressure; Circadian Rhythm; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Female; Humans; Hypertension, Renal; Indapamide; Indoles; Male; Middle Aged; Nitrendipine; Perindopril; Spironolactone | 2007 |
Determinants of new-onset diabetes among 19,257 hypertensive patients randomized in the Anglo-Scandinavian Cardiac Outcomes Trial--Blood Pressure Lowering Arm and the relative influence of antihypertensive medication.
Topics: Aged; Amlodipine; Antihypertensive Agents; Atenolol; Calcium Channel Blockers; Diabetic Angiopathies; Drug Therapy, Combination; England; Female; Humans; Hypertension; Male; Middle Aged; Patient Selection; Perindopril; Sweden | 2008 |
Hypertensive urgencies in the emergency department: evaluating blood pressure response to rest and to antihypertensive drugs with different profiles.
Topics: Amlodipine; Antihypertensive Agents; Blood Pressure; Combined Modality Therapy; Emergencies; Emergency Service, Hospital; Female; Follow-Up Studies; Humans; Hypertension; Labetalol; Male; Middle Aged; Perindopril; Rest; Retrospective Studies; Treatment Outcome | 2008 |
The Anglo-Scandinavian Cardiac Outcomes Trial: blood pressure-lowering limb: effects in patients with type II diabetes.
Topics: Adult; Aged; Amlodipine; Antihypertensive Agents; Atenolol; Blood Pressure; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Female; Humans; Hypertension; Male; Middle Aged; Perindopril; Peripheral Vascular Diseases; Scandinavian and Nordic Countries; Stroke; Thiazides; United Kingdom | 2008 |
Beneficial effects of combination therapy with angiotensin II receptor blocker and angiotensin-converting enzyme inhibitor on vascular endothelial function.
Topics: Aged; Amlodipine; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Flow Velocity; Blood Pressure; Calcium Channel Blockers; Drug Therapy, Combination; Endothelium, Vascular; Female; Heart Rate; Humans; Hypertension; Male; Middle Aged; Perindopril; Treatment Outcome; Vasodilation | 2008 |
Coronary heart disease benefits from blood pressure and lipid-lowering.
Topics: Amlodipine; Anticholesteremic Agents; Antihypertensive Agents; Atenolol; Atorvastatin; Blood Pressure; Coronary Disease; Heptanoic Acids; Humans; Hypertension; Perindopril; Pyrroles; Risk Factors; Risk Reduction Behavior; Sodium Chloride Symporter Inhibitors | 2009 |
Management of hypertension with the fixed combination of perindopril and amlodipine in daily clinical practice: results from the STRONG prospective, observational, multicenter study.
Topics: Adult; Aged; Amlodipine; Antihypertensive Agents; Blood Pressure; Clinical Medicine; Drug Combinations; Drug Resistance; Female; Humans; Hypertension; Male; Medication Adherence; Middle Aged; Perindopril | 2009 |
Ambulatory blood pressure monitoring predicts cardiovascular events in treated hypertensive patients--an Anglo-Scandinavian cardiac outcomes trial substudy.
Topics: Aged; Amlodipine; Atenolol; Blood Pressure Monitoring, Ambulatory; Drug Therapy, Combination; Female; Humans; Hypertension; Male; Middle Aged; Perindopril; Prospective Studies; Thiazides | 2009 |
Baseline heart rate, antihypertensive treatment, and prevention of cardiovascular outcomes in ASCOT (Anglo-Scandinavian Cardiac Outcomes Trial).
Topics: Aged; Amlodipine; Antihypertensive Agents; Atenolol; Bendroflumethiazide; Coronary Disease; Europe; Female; Heart Rate; Humans; Hypertension; Male; Middle Aged; Perindopril; Proportional Hazards Models; Treatment Outcome | 2009 |
[Perindopril, amlodipine and telmisartan improve arterial stiffness in patients with hypertension].
Topics: Aged; Amlodipine; Antihypertensive Agents; Benzimidazoles; Benzoates; Blood Pressure; Brachial Artery; Female; Humans; Hypertension; Male; Middle Aged; Perindopril; Telmisartan; Vascular Resistance | 2009 |
Bedtime versus at awakening administration of BP lowering drugs--is it the way to success?
Topics: Adult; Aged; Amlodipine; Antihypertensive Agents; Cohort Studies; Drug Chronotherapy; Female; Humans; Hypertension; Indoles; Male; Middle Aged; Perindopril; Treatment Outcome; Verapamil | 2009 |
Baseline predictors of resistant hypertension in the Anglo-Scandinavian Cardiac Outcome Trial (ASCOT): a risk score to identify those at high-risk.
Topics: Aged; Algorithms; Amlodipine; Antihypertensive Agents; Atenolol; Bendroflumethiazide; Diuretics; Drug Resistance; Female; Humans; Hypertension; Ireland; Male; Middle Aged; Perindopril; Risk Factors; Scandinavian and Nordic Countries; United Kingdom | 2011 |
[Uncontrolled arterial hypertension--new possibilities in solving problems of increasing the effectiveness of treatment].
Topics: Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure Monitoring, Ambulatory; Calcium Channel Blockers; Dose-Response Relationship, Drug; Drug Combinations; Drug Synergism; Female; Humans; Hypertension; Male; Middle Aged; Perindopril; Treatment Outcome | 2012 |
Optimization of blood pressure treatment with fixed-combination perindopril/amlodipine in patients with arterial hypertension.
Topics: Aged; Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Calcium Channel Blockers; Drug Combinations; Female; Humans; Hypertension; Longitudinal Studies; Male; Middle Aged; Perindopril; Prospective Studies | 2012 |
[Effect of a fixed-dose perindopril and amlodipine combination on intrarenal hemodynamic and kidney functional parameters in patients with essential hypertension].
Topics: Adult; Amlodipine; Antihypertensive Agents; Drug Combinations; Female; Glomerular Filtration Rate; Hemodynamics; Humans; Hypertension; Hypertension, Renal; Kidney Function Tests; Male; Middle Aged; Nephritis; Perindopril | 2013 |
[Combined therapy of arterial hypertension with the fixed combination of perindopril arginine / amlodipine in real clinical practice: the organization and the main results of the program CONSTANTA].
Topics: Adult; Aged; Aged, 80 and over; Amlodipine; Antihypertensive Agents; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Drug Combinations; Female; Humans; Hypertension; Male; Middle Aged; Perindopril; Program Development; Treatment Outcome | 2013 |
Long-term antihypertensive treatment fails to improve E/e' despite regression of left ventricular mass: an Anglo-Scandinavian cardiac outcomes trial substudy.
Topics: Adult; Aged; Amlodipine; Antihypertensive Agents; Atenolol; Bendroflumethiazide; Drug Therapy, Combination; Echocardiography, Doppler; Female; Humans; Hypertrophy, Left Ventricular; Male; Middle Aged; Perindopril; Time; Treatment Failure; Ventricular Function, Left; White People | 2014 |
The fixed-dose combination of olmesartan/amlodipine was superior in central aortic blood pressure reduction compared with perindopril/amlodipine: a randomized, double-blind trial in patients with hypertension.
Topics: Adult; Aged; Amlodipine; Confidence Intervals; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Drug Combinations; Female; Follow-Up Studies; Humans; Hypertension; Imidazoles; Male; Middle Aged; Multivariate Analysis; Perindopril; Risk Assessment; Tetrazoles; Treatment Outcome | 2013 |
Comparison of single-pill strategies first line in hypertension: perindopril/amlodipine versus valsartan/amlodipine.
Topics: Adult; Aged; Amlodipine; Amlodipine, Valsartan Drug Combination; Antihypertensive Agents; Blood Pressure; Double-Blind Method; Drug Combinations; Drug Therapy, Combination; Female; Humans; Hypertension; Indapamide; Male; Middle Aged; Perindopril; Valsartan | 2015 |
Randomized evaluation of a novel, fixed-dose combination of perindopril 3.5 mg/amlodipine 2.5 mg as a first-step treatment in hypertension.
Topics: Adolescent; Adult; Aged; Amlodipine; Antihypertensive Agents; Blood Pressure; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Hypertension; Male; Middle Aged; Perindopril; Treatment Outcome; Young Adult | 2015 |
Efficacy and safety of perindopril arginine + amlodipine in hypertension.
Topics: Amlodipine; Antihypertensive Agents; Diabetes Mellitus; Double-Blind Method; Drug Therapy, Combination; Edema; Female; Glomerular Filtration Rate; Humans; Hypertension; Male; Middle Aged; Perindopril; Potassium; Prospective Studies | 2015 |
Blood pressure reduction and control with fixed-dose combination perindopril/amlodipine: A Pan-Hellenic prospective observational study.
Topics: Amlodipine; Blood Pressure; Diastole; Dose-Response Relationship, Drug; Drug Combinations; Drug Therapy, Combination; Female; Greece; Humans; Male; Middle Aged; Perindopril; Prognosis; Prospective Studies; Systole | 2015 |
Investigation of a potential pharmacokinetic interaction between perindopril arginine and amlodipine when administered as a single perindopril/amlodipine fixed-dose combination tablet in healthy Chinese male volunteers.
Topics: Adult; Amlodipine; Antihypertensive Agents; Area Under Curve; Cross-Over Studies; Drug Combinations; Drug Interactions; Humans; Male; Perindopril; Tablets | 2016 |
Fixed-Combination Olmesartan/Amlodipine Was Superior to Perindopril + Amlodipine in Reducing Central Systolic Blood Pressure in Hypertensive Patients With Diabetes.
Topics: Aged; Amlodipine; Antihypertensive Agents; Blood Pressure; Diabetes Mellitus, Type 2; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Hypertension; Imidazoles; Male; Middle Aged; Perindopril; Tetrazoles; Treatment Outcome | 2016 |
Efficacy and Safety of Fixed-Dose Perindopril Arginine/Amlodipine in Hypertensive Patients Not Adequately Controlled with Amlodipine 5 mg or Perindopril tert-Butylamine 4 mg Monotherapy.
Topics: Aged; Amlodipine; Antihypertensive Agents; Blood Pressure; Double-Blind Method; Drug Combinations; Drug Monitoring; Drug Therapy, Combination; Essential Hypertension; Female; Humans; Hypertension; Male; Middle Aged; Perindopril; Treatment Outcome | 2016 |
Comparative study of the efficacy of olmesartan/amlodipine vs. perindopril/amlodipine in peripheral blood pressure after missed dose in type 2 diabetes.
Topics: Adult; Aged; Amlodipine; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Diabetes Mellitus, Type 2; Double-Blind Method; Drug Combinations; Essential Hypertension; Female; Humans; Hypertension; Imidazoles; Male; Medication Adherence; Middle Aged; Perindopril; Tetrazoles; Treatment Outcome | 2016 |
[New drug combination for initial therapy].
Topics: Amlodipine; Dose-Response Relationship, Drug; Drug Combinations; Europe; Humans; Hypertension; Perindopril | 2016 |
Comparative Study of the Efficacy of Olmesartan/Amlodipine vs. Perindopril/Amlodipine in Peripheral and Central Blood Pressure Parameters After Missed Dose in Type 2 Diabetes.
Topics: Aged; Amlodipine; Antihypertensive Agents; Blood Pressure; Diabetes Mellitus, Type 2; Female; Humans; Hypertension; Imidazoles; Male; Middle Aged; Perindopril; Pulse Wave Analysis; Tetrazoles | 2016 |
Short-Term Cardioprotective Effects of the Original Perindopril/Amlodipine Fixed-Dose Combination in Patients with Stable Coronary Artery Disease: Results of the PAPA-CAD Study.
Topics: Aged; Amlodipine; Antihypertensive Agents; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Cardiotonic Agents; Coronary Artery Disease; Drug Combinations; Drug Monitoring; Exercise Tolerance; Female; Heart Rate; Humans; Hungary; Hypertension; Male; Middle Aged; Perindopril; Prospective Studies; Risk Factors; Treatment Outcome | 2016 |
An evaluation of the effect of an angiotensin-converting enzyme inhibitor on the growth rate of small abdominal aortic aneurysms: a randomised placebo-controlled trial (AARDVARK).
Topics: Aged; Aged, 80 and over; Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Aortic Aneurysm, Abdominal; Blood Pressure; England; Humans; Likelihood Functions; Middle Aged; Perindopril; Single-Blind Method | 2016 |
Fixed-Dose Triple Combination of Antihypertensive Drugs Improves Blood Pressure Control: From Clinical Trials to Clinical Practice.
Topics: Aged; Amlodipine; Antihypertensive Agents; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Calcium Channel Blockers; Diuretics; Drug Combinations; Female; Humans; Hypertension; Indapamide; Male; Medication Adherence; Middle Aged; Perindopril | 2017 |
Blood pressure-lowering efficacy and safety of perindopril/indapamide/amlodipine single-pill combination in patients with uncontrolled essential hypertension: a multicenter, randomized, double-blind, controlled trial.
Topics: Adult; Aged; Amlodipine; Antihypertensive Agents; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Double-Blind Method; Drug Combinations; Essential Hypertension; Female; Humans; Indapamide; Male; Middle Aged; Perindopril; Treatment Outcome | 2017 |
Rationale and design of the comparison of 3 combination therapies in lowering blood pressure in black Africans (CREOLE study): 2 × 3 factorial randomized single-blind multicenter trial.
Topics: Adult; Africa South of the Sahara; Aged; Amlodipine; Antihypertensive Agents; Black People; Drug Combinations; Drug Therapy, Combination; Female; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Perindopril; Research Design; Single-Blind Method | 2018 |
Comparison of Dual Therapies for Lowering Blood Pressure in Black Africans.
Topics: Adult; Africa South of the Sahara; Aged; Amlodipine; Antihypertensive Agents; Black People; Blood Pressure; Drug Combinations; Drug Therapy, Combination; Female; Humans; Hydrochlorothiazide; Hypertension; Logistic Models; Male; Middle Aged; Perindopril; Single-Blind Method | 2019 |
Efficacy and Safety of Incremental Dosing of a New Single-Pill Formulation of Perindopril and Amlodipine in the Management of Hypertension.
Topics: Aged; Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Dose-Response Relationship, Drug; Double-Blind Method; Drug Combinations; Female; Humans; Hypertension; Male; Middle Aged; Perindopril; Severity of Illness Index | 2019 |
Short-term effects of perindopril-amlodipine vs perindopril-indapamide on blood pressure control in sub-Saharan type 2 diabetic individuals newly diagnosed for hypertension: A double-blinded randomized controlled trial.
Topics: Africa South of the Sahara; Amlodipine; Antihypertensive Agents; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Comorbidity; Diabetes Mellitus, Type 2; Double-Blind Method; Drug Combinations; Drug Monitoring; Female; Humans; Hypertension; Indapamide; Male; Middle Aged; Perindopril; Treatment Outcome | 2019 |
Long-term effect of the perindopril/indapamide/amlodipine single-pill combination on left ventricular hypertrophy in outpatient hypertensive subjects.
Topics: Amlodipine; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Drug Combinations; Female; Follow-Up Studies; Humans; Hypertension; Hypertrophy, Left Ventricular; Indapamide; Male; Middle Aged; Outpatients; Perindopril; Systole; Time Factors | 2019 |
Blood-pressure Lowering Efficacy and Safety of Perindopril / Indapamide / Amlodipine Single-pill Combination in Hypertensive Patients: Phase III Trial in India.
Topics: Amlodipine; Antihypertensive Agents; Blood Pressure; Drug Combinations; Humans; Hypertension; Indapamide; India; Perindopril; Quality of Life; Treatment Outcome | 2020 |
A Differential Response to Antihypertensive Therapy in African Men and Women: Insights From the CREOLE Trial.
Topics: Amlodipine; Antihypertensive Agents; Black People; Blood Pressure; Double-Blind Method; Drug Combinations; Drug Therapy, Combination; Female; Humans; Hydrochlorothiazide; Hypertension; Male; Perindopril; Treatment Outcome | 2022 |
Effect of 3, 2-Drug Combinations of Antihypertensive Therapies on Blood Pressure Variability in Black African Patients: Secondary Analyses of the CREOLE Trial.
Topics: Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Calcium Channel Blockers; Drug Combinations; Drug Therapy, Combination; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Perindopril; Thiazides | 2022 |
114 other study(ies) available for amlodipine and perindopril
| Article | Year |
|---|---|
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Capture hydrolysis signals in the microsomal stability assay: molecular mechanisms of the alkyl ester drug and prodrug metabolism.
Topics: Carboxylic Acids; Cytochrome P-450 Enzyme System; Esters; Humans; Hydrolysis; Microsomes; Models, Molecular; Molecular Structure; Prodrugs; Quantum Theory; Signal Transduction | 2012 |
Endothelium-dependent relaxation in resistance arteries from spontaneously hypertensive rats: effect of long-term treatment with perindopril, quinapril, hydralazine or amlodipine.
Topics: Acetylcholine; Amlodipine; Animals; Antihypertensive Agents; Arginine; Bradykinin; Dose-Response Relationship, Drug; Endothelium, Vascular; Hydralazine; Hypertension; Indoles; Isoquinolines; Mesenteric Arteries; Nitroarginine; Perindopril; Quinapril; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Tetrahydroisoquinolines; Vasodilation | 1996 |
Cardiovascular effects of combination of perindopril, candesartan, and amlodipine in hypertensive rats.
Topics: Adrenergic beta-Antagonists; Amlodipine; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Angiotensins; Animals; Antihypertensive Agents; Aorta; Atrial Natriuretic Factor; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Bradykinin; Calcium; Calcium Channel Blockers; Drug Therapy, Combination; ErbB Receptors; Gene Expression; Heart Ventricles; Hypertension; Myocardium; Organ Size; Perindopril; Phosphorylation; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; Receptors, Platelet-Derived Growth Factor; RNA, Messenger; Stroke; Tetrazoles | 2000 |
Pulmonary vascular remodelling in hypoxic rats: effects of amlodipine, alone and with perindopril.
Topics: Amlodipine; Animals; Antihypertensive Agents; Blood Pressure; Heart Ventricles; Hypertension, Pulmonary; Hypertrophy; Hypoxia; In Vitro Techniques; Lung; Male; Organ Size; Perindopril; Pulmonary Artery; Rats; Rats, Wistar; Vascular Resistance; Vasoconstriction | 2001 |
Anglo-Scandinavian Cardiac Outcomes Trial: a brief history, rationale and outline protocol.
Topics: Amlodipine; Antihypertensive Agents; Atenolol; Benzothiadiazines; Coronary Disease; Diuretics; Humans; Hypertension; Myocardial Infarction; Perindopril; Randomized Controlled Trials as Topic; Sodium Chloride Symporter Inhibitors | 2001 |
Vasoactive peptides and procollagen propeptides in patients with hypertension in relation to cardiac hypertrophy and diastolic heart failure: design of the study and patient characteristics.
Topics: Amlodipine; Antihypertensive Agents; Atenolol; Atrial Natriuretic Factor; Bendroflumethiazide; Cardiomegaly; Endothelin-1; Female; Heart Failure; Humans; Hypertension; Male; Middle Aged; Natriuretic Peptide, Brain; Perindopril; Procollagen; Randomized Controlled Trials as Topic | 2001 |
[ASCOT-BPLA Study raises new questions regarding: which is the best initial antihypertensive drug?].
Topics: Adrenergic beta-Antagonists; Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Atenolol; Atorvastatin; Calcium Channel Blockers; Cardiovascular Diseases; Doxazosin; Drug Therapy, Combination; Follow-Up Studies; Heptanoic Acids; Humans; Hypertension; Perindopril; Pyrroles; Sodium Chloride Symporter Inhibitors; Treatment Outcome | 2005 |
The prevention of myocardial ultrastructural changes by perindopril, atenolol and amlodipine in chronic alcohol administered rats.
Topics: Adrenergic beta-Antagonists; Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Animals; Atenolol; Calcium Channel Blockers; Central Nervous System Depressants; Ethanol; Male; Microscopy, Electron; Myocardium; Perindopril; Rats; Rats, Wistar | 2006 |
[ASCOT Study of optimal hypertension therapy. New study results against the "diuretics first" recommendation].
Topics: Adrenergic beta-Antagonists; Adult; Aged; Amlodipine; Antihypertensive Agents; Cardiovascular Diseases; Contraindications; Cross-Over Studies; Diuretics; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Hypertension; Long-Term Care; Male; Middle Aged; Perindopril; Randomized Controlled Trials as Topic; Treatment Outcome | 2005 |
[Antihypertensive therapy: campaign of the giants].
Topics: Adult; Aged; Amlodipine; Antihypertensive Agents; Atenolol; Bendroflumethiazide; Coronary Disease; Drug Therapy, Combination; Humans; Hypertension; Middle Aged; Multicenter Studies as Topic; Myocardial Infarction; Perindopril; Randomized Controlled Trials as Topic; Survival Analysis | 2005 |
Results of the ASCOT-BPLA trial: no practical implications for treatment of hypertension.
Topics: Amlodipine; Atenolol; Cardiovascular Diseases; Clinical Trials as Topic; Drug Therapy, Combination; Humans; Hypertension; Perindopril; Sodium Chloride Symporter Inhibitors; Treatment Outcome | 2006 |
Letter by Safar and Fournier regarding article, "Differential impact of blood pressure-lowering drugs on central aortic pressure and clinical outcomes: principal results of the Conduit Artery Function Evaluation (CAFE) study".
Topics: Adrenergic beta-Antagonists; Amlodipine; Antihypertensive Agents; Aorta; Atenolol; Blood Pressure; Heart Rate; Humans; Hypertension; Indapamide; Perindopril; Proportional Hazards Models; Reproducibility of Results; Stroke Volume; Treatment Outcome | 2006 |
Pulsology reloaded: commentary on similar effects of treatment on central and brachial blood pressure in older hypertensive subjects.
Topics: Aged; Aged, 80 and over; Aging; Amlodipine; Antihypertensive Agents; Atenolol; Blood Pressure; Brachial Artery; Enalapril; Humans; Hydrochlorothiazide; Hypertension; Losartan; Manometry; Perindopril; Ultrasonography, Doppler | 2007 |
[Treating essential hypertension. Are beta blockers still first choice?].
Topics: Adrenergic beta-Antagonists; Amlodipine; Antihypertensive Agents; Atenolol; Bendroflumethiazide; Coronary Disease; Drug Therapy, Combination; Humans; Hypertension; Multicenter Studies as Topic; Myocardial Infarction; Outcome Assessment, Health Care; Perindopril; Practice Guidelines as Topic; Randomized Controlled Trials as Topic; Stroke | 2007 |
ACE inhibition and AT1 receptor blockade prevent fatty liver and fibrosis in obese Zucker rats.
Topics: Amlodipine; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Biphenyl Compounds; Disease Models, Animal; Fatty Liver; Interleukin-6; Irbesartan; Liver; Liver Cirrhosis; Male; Metabolic Syndrome; Obesity; Perindopril; Rats; Rats, Zucker; Renin-Angiotensin System; Tetrazoles; Transforming Growth Factor beta; Tumor Necrosis Factor-alpha | 2008 |
Perindopril, atenolol, and amlodipine prevent aortic ultrastructural changes in rats exposed to ethanol.
Topics: Adrenergic beta-Antagonists; Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Animals; Aorta; Atenolol; Calcium Channel Blockers; Endothelial Cells; Ethanol; Male; Microscopy, Electron; Perindopril; Rats; Rats, Wistar | 2008 |
A stunning day in hypertension research - Results of ONTARGET, ACCOMPLISH and HYVET.
Topics: Amlodipine; Antihypertensive Agents; Benzazepines; Benzimidazoles; Benzoates; Clinical Trials as Topic; Drug Therapy, Combination; Humans; Hypertension; Indapamide; Perindopril; Ramipril; Telmisartan | 2008 |
Application in the STRATHE trial of a score system to compare the efficacy and the tolerability of different therapeutic strategies in the management of hypertension.
Topics: Amlodipine; Antihypertensive Agents; Atenolol; Double-Blind Method; Drug Therapy, Combination; France; Humans; Hydrochlorothiazide; Hypertension; Indapamide; Losartan; Perindopril; Randomized Controlled Trials as Topic; Tetrazoles; Treatment Outcome; Valine; Valsartan | 2008 |
[Hypertension--does it matter how blood pressure is lowered?].
Topics: Amlodipine; Anticholesteremic Agents; Antihypertensive Agents; Atenolol; Atorvastatin; Bendroflumethiazide; Cardiovascular Diseases; Cost-Benefit Analysis; Diuretics; Drug Administration Schedule; Drug Therapy, Combination; Evidence-Based Medicine; Heptanoic Acids; Humans; Hypertension; Perindopril; Pyrroles; Treatment Outcome | 2008 |
[Fixed combination perindopril-amlodipine (Coveram) in the treatment of hypertension and coronary heart disease].
Topics: Administration, Oral; Amlodipine; Antihypertensive Agents; Coronary Disease; Drug Combinations; Humans; Hypertension; Perindopril; Treatment Outcome | 2009 |
Ethnic differences in blood pressure response to first and second-line antihypertensive therapies in patients randomized in the ASCOT Trial.
Topics: Age Factors; Amlodipine; Antihypertensive Agents; Atenolol; Blood Pressure; Confounding Factors, Epidemiologic; Diuretics; Drug Therapy, Combination; Female; Humans; Hypertension; Male; Middle Aged; Multicenter Studies as Topic; Perindopril; Racial Groups; Randomized Controlled Trials as Topic; Sex Factors; Treatment Outcome | 2010 |
Efficacy of Sevikar® compared to the combination of perindopril plus amlodipine on central arterial blood pressure in patients with moderate-to-severe hypertension: Rationale and design of the SEVITENSION study.
Topics: Aged; Amlodipine; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Aorta; Calcium Channel Blockers; Confidence Intervals; Double-Blind Method; Female; Humans; Hypertension; Imidazoles; Male; Middle Aged; Perindopril; Renin-Angiotensin System; Research Design; Severity of Illness Index; Tetrazoles | 2011 |
[Combination of perindopril and amlodipine as optimal basis for realization of desirable clinical effects in the treatment of arterial hypertension with fixed drug combination].
Topics: Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Calcium Channel Blockers; Cardiotonic Agents; Drug Combinations; Drug Synergism; Heart Rate; Humans; Hypertension; Microcirculation; Myocardial Ischemia; Perindopril; Renin-Angiotensin System; Secondary Prevention; Vasomotor System | 2011 |
[Pharmaco-economical aspects of treatment of patients with arterial hypertension with fixed perindopril/amlodipine combination].
Topics: Aged; Amlodipine; Antihypertensive Agents; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Costs and Cost Analysis; Drug Combinations; Drug Synergism; Female; Humans; Hypertension; Male; Medication Therapy Management; Middle Aged; Perindopril; Secondary Prevention; Treatment Outcome | 2011 |
[Estimation of antihypertension efficiency and use of fixed combination perindopril+amlodipin by uncontrollable hypertension patients within the limits of routine treatment].
Topics: Adult; Aged; Aged, 80 and over; Amlodipine; Biological Availability; Blood Pressure Monitoring, Ambulatory; Dose-Response Relationship, Drug; Drug Combinations; Drug Monitoring; Drug Resistance; Drug Synergism; Female; Heart Rate; Humans; Hypertension; Male; Middle Aged; Perindopril; Severity of Illness Index; Treatment Outcome | 2011 |
A new dimension in hypertension management with the amlodipine/perindopril combination.
Topics: Amlodipine; Antihypertensive Agents; Humans; Hypertension; Perindopril; Randomized Controlled Trials as Topic; Treatment Failure | 2011 |
The safe introduction of angiotensin-converting enzyme inhibitor in renal allograft recipients.
Topics: Adult; Aged; Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Female; Humans; Kidney Transplantation; Male; Middle Aged; Perindopril; Ramipril; Transplantation, Homologous | 2012 |
Validated chromatographic methods for determination of perindopril and amlodipine in pharmaceutical formulation in the presence of their degradation products.
Topics: Amlodipine; Analysis of Variance; Chromatography, High Pressure Liquid; Chromatography, Thin Layer; Densitometry; Drug Stability; Perindopril; Regression Analysis; Reproducibility of Results; Sensitivity and Specificity; Tablets | 2013 |
Asymptomatic carotid stenosis.
Topics: Aged; Amlodipine; Anticholesteremic Agents; Aspirin; Asymptomatic Diseases; Atorvastatin; Azetidines; Carotid Stenosis; Diet, Mediterranean; Drug Therapy, Combination; Exercise Therapy; Ezetimibe; Female; Heptanoic Acids; Humans; Perindopril; Pyrroles; Risk; Stroke; Treatment Outcome; Ultrasonography; Vasodilator Agents | 2013 |
Twenty-four-hour ambulatory blood pressure reduction with a perindopril/amlodipine fixed-dose combination.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amlodipine; Antihypertensive Agents; Blood Pressure; Drug Combinations; Female; Humans; Hypertension; Male; Middle Aged; Perindopril; Prospective Studies; Young Adult | 2013 |
Antihypertensive efficacy of triple combination perindopril/indapamide plus amlodipine in high-risk hypertensives: results of the PIANIST study (Perindopril-Indapamide plus AmlodipiNe in high rISk hyperTensive patients).
Topics: Adult; Aged; Aged, 80 and over; Amlodipine; Antihypertensive Agents; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Drug Combinations; Drug Therapy, Combination; Female; Heart Rate; Humans; Hypertension; Indapamide; Male; Middle Aged; Perindopril; Prospective Studies; Risk Factors | 2014 |
[Effect of fixed-dose combination of perindopril A/amlodipine on inter visit-to-visit and inter visit blood pressure and heart rate variability in real clinical practice in the Russian observation program KONSTANTA].
Topics: Adult; Aged; Aged, 80 and over; Ambulatory Care; Amlodipine; Blood Pressure; Blood Pressure Determination; Dose-Response Relationship, Drug; Drug Combinations; Female; Heart Rate; Humans; Hypertension; Male; Middle Aged; Perindopril; Russia; Young Adult | 2014 |
Additional information regarding the SEVITENSION study.
Topics: Amlodipine; Female; Humans; Hypertension; Imidazoles; Male; Perindopril; Tetrazoles | 2014 |
Triple combination therapy in hypertension: the antihypertensive efficacy of treatment with perindopril, amlodipine, and indapamide SR.
Topics: Aged; Amlodipine; Antihypertensive Agents; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Delayed-Action Preparations; Drug Combinations; Drug Therapy, Combination; Female; Humans; Hypertension; Indapamide; Male; Middle Aged; Perindopril; Prospective Studies; Treatment Outcome | 2014 |
Single-pill combination therapy in the initial treatment of marked hypertension: a propensity-matched analysis.
Topics: Amlodipine; Antihypertensive Agents; Benzimidazoles; Benzoates; Blood Pressure; Dihydropyridines; Dose-Response Relationship, Drug; Drug Combinations; Enalapril; Female; Humans; Hydrochlorothiazide; Hypertension; Imidazoles; Male; Middle Aged; Perindopril; Propensity Score; Ramipril; Retrospective Studies; Risk Factors; Telmisartan; Tetrazoles | 2015 |
[Organoprotective effects of the combination of perindopril and amlodipine depending on the renal functional state in patients with arterial hypertension].
Topics: Amlodipine; Antihypertensive Agents; Drug Combinations; Female; Hemodynamics; Humans; Hypertension; Kidney; Male; Middle Aged; Perindopril; Treatment Outcome | 2013 |
[Fixed dose combination perindopril-indapamide-amlodipine (Triplixam) for the treatment of arterial hypertension].
Topics: Amlodipine; Antihypertensive Agents; Blood Pressure; Drug Combinations; Drug Synergism; Humans; Hypertension; Indapamide; Medication Adherence; Perindopril; Precision Medicine | 2014 |
[Efficacy of a fixed-dose combination of perindopril and amlodipine in the treatment of hypertensive patients. A clinical case].
Topics: Amlodipine; Antihypertensive Agents; Drug Combinations; Humans; Hypertension; Male; Middle Aged; Perindopril; Treatment Outcome | 2014 |
[Hypertensive patients' adherence, motivation, and awareness during fixed-dose perindopril A and amlodipine combination treatment (results of the CONSTANTA trial)].
Topics: Aged; Amlodipine; Antihypertensive Agents; Clinical Trials as Topic; Drug Combinations; Female; Humans; Hypertension; Male; Medication Adherence; Middle Aged; Perindopril; Treatment Outcome | 2015 |
Comparison of single-pill strategies first line in hypertension: perindopril/amlodipine versus valsartan/amlodipine.
Topics: Amlodipine; Amlodipine, Valsartan Drug Combination; Antihypertensive Agents; Female; Humans; Hypertension; Male; Perindopril | 2015 |
Comparison of single-pill strategies first line in hypertension: perindopril/amlodipine versus valsartan/amlodipine.
Topics: Amlodipine; Amlodipine, Valsartan Drug Combination; Antihypertensive Agents; Female; Humans; Hypertension; Male; Perindopril | 2015 |
[Optimization of treatment in hypertensive patients in real clinical practice: Role of a fixed-dose perindopril A and amlodipine combination (Results of the Russian observational CONSTANTA trial].
Topics: Adult; Aged; Amlodipine; Antihypertensive Agents; Blood Pressure; Drug Combinations; Female; Heart Rate; Humans; Hypertension; Male; Middle Aged; Perindopril; Risk Factors; Russia; Treatment Outcome | 2015 |
Conventional univariate versus multivariate spectrophotometric assisted techniques for simultaneous determination of perindopril arginin and amlodipine besylate in presence of their degradation products.
Topics: Amlodipine; Antihypertensive Agents; Drug Combinations; Drug Stability; Multivariate Analysis; Perindopril; Spectrophotometry | 2015 |
Novel ratio difference at coabsorptive point spectrophotometric method for determination of components with wide variation in their absorptivities.
Topics: Amlodipine; Antihypertensive Agents; Drug Combinations; Limit of Detection; Perindopril; Spectrophotometry, Ultraviolet | 2016 |
[The Fixed Combination of Perindopril A/Amlodipine--a Rational Choice to Improve the Control of Hypertension in Clinical Practice (Results of the Program KONSTANT observational program)].
Topics: Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Calcium Channel Blockers; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Humans; Hypertension; Male; Middle Aged; Perindopril; Treatment Outcome | 2015 |
Perindopril arginine + amlodipine for the treatment of hypertension in the USA.
Topics: Amlodipine; Antihypertensive Agents; Blood Pressure; Drug Combinations; Humans; Hypertension; Perindopril; Randomized Controlled Trials as Topic; United States | 2015 |
Effectiveness of Fixed-Dose Perindopril/Amlodipine on Clinic, Ambulatory and Self-Monitored Blood Pressure and Blood Pressure Variability: An Open-Label, Non Comparative Study in the General Practice.
Topics: Adult; Aged; Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Calcium Channel Blockers; Drug Combinations; Female; General Practice; Humans; Hypertension; Male; Middle Aged; Observer Variation; Office Visits; Perindopril; Predictive Value of Tests; Reproducibility of Results; Russia; Time Factors; Treatment Outcome | 2015 |
Drug updates and approvals: 2015 in review.
Topics: Amlodipine; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Atazanavir Sulfate; Azabicyclo Compounds; Benzazepines; Ceftazidime; Cobicistat; Drug Approval; Drug Combinations; Humans; Injections, Subcutaneous; Ivabradine; Liraglutide; Nurse Practitioners; Perindopril; Pyridines; Thiazoles; United States; United States Food and Drug Administration | 2015 |
[EFFECTIVENESS OF FIXED COMBINATION OF PERINDOPRILARGININE AND AMLODIPINE FOR THE TREATMENT OF ARTERIAL HYPERTENSION WITH CONCOMITANT CHRONIC CARDIAC INSUFFICIENCY AND SIGNS OF CHRONIC KIDNEY DISEASE].
Topics: Aged; Amlodipine; Antihypertensive Agents; Blood Pressure; Drug Combinations; Drug Monitoring; Female; Follow-Up Studies; Heart Failure; Humans; Hypertension; Kidney Function Tests; Male; Middle Aged; Perindopril; Prospective Studies; Renal Insufficiency, Chronic; Russia; Severity of Illness Index; Treatment Outcome | 2015 |
[Therapy of Arterial Hypertension in Patients With Chronic Heart Failure and Signs of Chronic Kidney Disease With Fixed Perindopril/Amlodipine Combination].
Topics: Amlodipine; Antihypertensive Agents; Blood Pressure; Dose-Response Relationship, Drug; Drug Combinations; Essential Hypertension; Female; Glomerular Filtration Rate; Heart Failure; Humans; Hypertension; Male; Middle Aged; Perindopril; Renal Insufficiency, Chronic; Treatment Outcome | 2015 |
The Efficacy of Perindopril/Amlodipine in Reaching Blood Pressure Targets: Results of the CONTROL Study.
Topics: Adult; Aged; Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Cohort Studies; Drug Combinations; Essential Hypertension; Female; Follow-Up Studies; Humans; Hypertension; Male; Middle Aged; Perindopril; Saudi Arabia; Treatment Outcome | 2016 |
[New fixed dose combination for initial control of hypertension].
Topics: Amlodipine; Antihypertensive Agents; Blood Pressure; Delayed-Action Preparations; Dose-Response Relationship, Drug; Drug Combinations; Humans; Hypertension; Perindopril | 2016 |
Switching from a Free Association of Perindopril/Amlodipine to a Fixed-Dose Combination: Increased Antihypertensive Efficacy and Tolerability.
Topics: Adult; Aged; Amlodipine; Antihypertensive Agents; Blood Pressure; Cohort Studies; Diabetes Mellitus, Type 2; Drug Combinations; Edema; Female; Humans; Hypertension; Longitudinal Studies; Male; Middle Aged; Perindopril; Prospective Studies; Risk Factors | 2016 |
[The Possibilities of Pharmacological Correction of Endothelial Dysfunction in Patients With Arterial Hypertension].
Topics: Amlodipine; Antihypertensive Agents; Blood Pressure; Drug Combinations; Female; Humans; Hypertension; Male; Middle Aged; Perindopril; Treatment Outcome | 2015 |
Effectiveness of perindopril/amlodipine fixed dose combination in everyday clinical practice: results from the EMERALD study.
Topics: Aged; Amlodipine; Antihypertensive Agents; Blood Pressure; Drug Combinations; Female; Humans; Hypertension; Male; Middle Aged; Perindopril | 2016 |
Efficacy and Safety Assessment of Hypertension Management with Coveram (Perindopril/Amlodipine Fixed Combination) in Patients with Previous Angiotensin Receptor Blocker (ARB) Treatment: Arabian Gulf STRONG Study.
Topics: Adult; Aged; Aged, 80 and over; Amlodipine; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Drug Combinations; Drug Substitution; Female; Humans; Hypertension; Male; Middle Aged; Middle East; Perindopril; Time Factors; Treatment Outcome | 2016 |
Impact of Statin Therapy on the Blood Pressure-Lowering Efficacy of a Single-Pill Perindopril/Amlodipine Combination in Hypertensive Patients with Hypercholesterolemia.
Topics: Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Biomarkers; Blood Pressure; Calcium Channel Blockers; Drug Combinations; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Hypertension; Lipids; Male; Middle Aged; Perindopril; Risk Factors; Time Factors; Treatment Outcome; Ukraine | 2017 |
A Validated HPLC Method for Simultaneous Determination of Perindopril Arginine, Amlodipine, and Indapamide: Application in Bulk and in Different Pharmaceutical Dosage Forms.
Topics: Amlodipine; Chromatography, High Pressure Liquid; Indapamide; Perindopril | 2017 |
Inhibition of the Renin-Angiotensin System Post Myocardial Infarction Prevents Inflammation-Associated Acute Cardiac Rupture.
Topics: Amlodipine; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Anti-Inflammatory Agents; Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Chemotaxis, Leukocyte; Cytokines; Disease Models, Animal; Dose-Response Relationship, Drug; Heart Rupture, Post-Infarction; Inflammation; Inflammation Mediators; Losartan; Male; Mice, 129 Strain; Monocytes; Myocardial Infarction; Myocardium; Neutrophil Infiltration; Neutrophils; Perindopril; Renin-Angiotensin System; Spleen; Time Factors | 2017 |
[Efficacy and Safety of a Fixed Combination of Perindopril Arginine and Amlodipine in Patients With Hypertension Uncontrolled by Treatment With Angiotensin II Receptor Blockers in Real Clinical Practice. Results of the PREVOSHODSTVO (SUPERIORITY) Program]
Topics: Aged; Amlodipine; Angiotensin Receptor Antagonists; Antihypertensive Agents; Arginine; Blood Pressure; Drug Combinations; Female; Humans; Hypertension; Male; Middle Aged; Perindopril; Treatment Outcome | 2017 |
[The Use of Fixed Perindopril A/Amlodipine Combination Provides High Compliance to Therapy, Effective and Safe Arterial Pressure Lowering in Patients With Previous Inefferctive Therapy. The POTENTIAL Program].
Topics: Amlodipine; Antihypertensive Agents; Arterial Pressure; Drug Combinations; Female; Humans; Hypertension; Male; Middle Aged; Patient Compliance; Perindopril; Treatment Outcome | 2015 |
Case of Asymptomatic Carotid Artery Stenosis in a Hypertensive Patient.
Topics: Aged; Amlodipine; Antihypertensive Agents; Carotid Stenosis; Diuretics; Echocardiography, Doppler; Humans; Hypertension; Male; Perindopril | 2017 |
Adherence to Treatment, Safety, Tolerance, and Effectiveness of Perindopril/Amlodipine Fixed-Dose Combination in Greek Patients with Hypertension and Stable Coronary Artery Disease: A Pan-Hellenic Prospective Observational Study of Daily Clinical Practice
Topics: Aged; Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Coronary Artery Disease; Drug Combinations; Drug Tolerance; Female; Greece; Humans; Hypertension; Male; Perindopril; Prospective Studies | 2017 |
The Antihypertensive Efficacy of the Triple Fixed Combination of Perindopril, Indapamide, and Amlodipine: The Results of the PETRA Study.
Topics: Adult; Amlodipine; Antihypertensive Agents; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Drug Combinations; Female; Humans; Hungary; Hypertension; Indapamide; Male; Middle Aged; Perindopril; Prospective Studies | 2017 |
Combination cardiovascular drugs.
Topics: Aminobutyrates; Amlodipine; Aspirin; Biphenyl Compounds; Cardiovascular Agents; Cardiovascular Diseases; Drug Combinations; Humans; Nebivolol; Omeprazole; Perindopril; Tetrazoles; Valsartan | 2017 |
[Optimization of BP Control and Arterial Elasticity With Fixed Combination Therapy Perindopril and Amlodipine In Patients With Arterial Hypertension and Increased Pulse Wave Velocity].
Topics: Adult; Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Calcium Channel Blockers; Diuretics; Drug Combinations; Female; Humans; Hypertension; Male; Middle Aged; Perindopril; Pulse Wave Analysis | 2017 |
Long-term persistence with single-pill, fixed-dose combination therapy versus two pills of amlodipine and perindopril for hypertension: Australian experience.
Topics: Aged; Amlodipine; Antihypertensive Agents; Australia; Drug Combinations; Drug Therapy, Combination; Female; Humans; Hypertension; Male; Perindopril; Retrospective Studies | 2017 |
Klippel-Trenaunay-Weber syndrome with atypical presentation of hypersplenism and nephrotic syndrome: a case report.
Topics: Adult; Allopurinol; Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Anticholesteremic Agents; Antihypertensive Agents; Arteriovenous Fistula; Atorvastatin; Cholecalciferol; Erythrocyte Transfusion; Humans; Hypersplenism; Klippel-Trenaunay-Weber Syndrome; Male; Nephrotic Syndrome; Perindopril; Port-Wine Stain; Vitamins | 2017 |
[One year persistence of free and fixed dose combinations of perindopril/amlodipine].
Topics: Amlodipine; Antihypertensive Agents; Drug Administration Schedule; Drug Combinations; Drug Prescriptions; Humans; Hungary; Hypertension; Medication Adherence; Perindopril; Survival Analysis | 2017 |
[Blood Pressure Variability. Visit-to-Visit Blood Pressure Variability].
Topics: Amlodipine; Antihypertensive Agents; Blood Pressure; Blood Pressure Determination; Drug Combinations; Humans; Hypertension; Perindopril | 2017 |
Modifications in drug adherence after switch to fixed-dose combination of perindopril/amlodipine in clinical practice. Results of a large-scale Italian experience. The amlodipine-perindopril in real settings (AMPERES) study.
Topics: Adult; Aged; Amlodipine; Antihypertensive Agents; Blood Pressure; Drug Combinations; Drug Substitution; Drug Therapy, Combination; Female; Humans; Hypertension; Italy; Male; Medication Adherence; Middle Aged; Outcome and Process Assessment, Health Care; Perindopril; Retrospective Studies | 2018 |
[24‑Hour Arterial Pressure Variability: Prognostic Significance, Methods of Evaluation, Effect of Antihypertensive Therapy].
Topics: Amlodipine; Antihypertensive Agents; Arterial Pressure; Drug Combinations; Humans; Hypertension; Perindopril; Prognosis | 2017 |
Effectiveness of a Fixed-Dose, Single-Pill Combination of Perindopril and Amlodipine in Patients with Hypertension: A Non-Interventional Study.
Topics: Aged; Amlodipine; Antihypertensive Agents; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Drug Combinations; Female; Germany; Humans; Hypertension; Male; Medication Adherence; Middle Aged; Outcome Assessment, Health Care; Perindopril; Primary Health Care; Prospective Studies | 2018 |
Treatment with triple combination of atorvastatin, perindopril, and amlodipine in patients with stable coronary artery disease: A subgroup analysis from the PAPA-CAD study.
Topics: Amlodipine; Atorvastatin; Blood Pressure; Coronary Artery Disease; Drug Combinations; Electrocardiography; Female; Heart Rate; Humans; Male; Middle Aged; Perindopril; Risk Factors | 2018 |
[Assessment of Efficacy of Combined Pharmacotherapy With Fixed Perindopril/Amlodipine Combination in Patients With Combined Cardiovascular Pathology in Outpatient Practice].
Topics: Aged; Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Drug Combinations; Humans; Hypertension; Middle Aged; Outpatients; Perindopril | 2018 |
[Influence of Therapy With Fixed Combination of Perindopril and Amlodipine on Parameters of Elasticity of Main Vessels and Microcirculation in Patients With Arterial Hypertension and Type 2 Diabetes Mellitus].
Topics: Aged; Amlodipine; Antihypertensive Agents; Blood Pressure; Diabetes Mellitus, Type 2; Drug Combinations; Elasticity; Humans; Hypertension; Microcirculation; Middle Aged; Perindopril; Pulse Wave Analysis | 2018 |
Perindopril 3.5 mg/amlodipine 2.5 mg versus renin-angiotensin system inhibitor monotherapy as first-line treatment in hypertension: a combined analysis.
Topics: Aged; Amlodipine; Antihypertensive Agents; Blood Pressure; Drug Combinations; Female; Humans; Hypertension; Irbesartan; Male; Middle Aged; Perindopril; Randomized Controlled Trials as Topic; Renin-Angiotensin System; Valsartan | 2018 |
Diabetic patients with essential hypertension treated with amlodipine: blood pressure and arterial stiffness effects of canagliflozin or perindopril.
Topics: Aged; Amlodipine; Antihypertensive Agents; Blood Pressure; Canagliflozin; Diabetes Mellitus, Type 2; Essential Hypertension; Female; Humans; Male; Middle Aged; Perindopril; Sodium-Glucose Transporter 2 Inhibitors; Vascular Stiffness | 2019 |
[Day-by Day Blood Pressure Variability: Methodological Aspects, Prognostic Value, Effects of Antihypertensive Therapy].
Topics: Amlodipine; Antihypertensive Agents; Blood Pressure; Drug Combinations; Humans; Hypertension; Perindopril; Prognosis | 2018 |
[Combined Therapy of Arterial Hypertension With Triple Fixed-Dose Combination of Amlodipine/Indapamide/Perindopril Arginine in Real Clinical Practice: the Organization and the Main Results of the DOKAZATEL'STVO (Proof) Study].
Topics: Academic Medical Centers; Aged; Amlodipine; Antihypertensive Agents; Arginine; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Drug Combinations; Female; Humans; Hypertension; Indapamide; Male; Middle Aged; Patient Compliance; Perindopril; Russia | 2018 |
α-Lipoic acid and amlodipine/perindopril combination potentiate the therapeutic effect of mesenchymal stem cells on isoproterenol induced cardiac injury in rats.
Topics: Amlodipine; Animals; Drug Therapy, Combination; Heart Injuries; Isoproterenol; Male; Mesenchymal Stem Cell Transplantation; Mesenchymal Stem Cells; Perindopril; Rats; Rats, Wistar; Thioctic Acid | 2019 |
Topics: Amlodipine; Antihypertensive Agents; Blood Pressure; Drug Combinations; Female; Humans; Hypertension; Indapamide; Male; Perindopril; Prospective Studies; Treatment Outcome | 2018 |
Topics: Amlodipine; Antihypertensive Agents; Blood Pressure; Drug Combinations; Humans; Hypertension; Myocardial Ischemia; Perindopril | 2019 |
Effectiveness and Adherence to Treatment with Perindopril/Indapamide/Amlodipine Single-Pill Combination in a Greek Population with Hypertension.
Topics: Adult; Aged; Amlodipine; Antihypertensive Agents; Blood Pressure; Drug Combinations; Female; Greece; Humans; Hypertension; Indapamide; Male; Medication Adherence; Middle Aged; Perindopril; Prospective Studies | 2019 |
Utility of fixed-dose single tablet antihypertensive drug combinations in Cameroonians with type 2 diabetes and newly diagnosed hypertension.
Topics: Africa South of the Sahara; Amlodipine; Antihypertensive Agents; Blood Pressure; Diabetes Mellitus, Type 2; Drug Combinations; Humans; Hypertension; Indapamide; Perindopril; Tablets | 2019 |
Treatment of Hypertensive and Hypercholesterolaemic Patients with the Triple Fixed Combination of Atorvastatin, Perindopril and Amlodipine: The Results of the CORAL Study.
Topics: Adult; Aged; Aged, 80 and over; Amlodipine; Animals; Anticholesteremic Agents; Antihypertensive Agents; Atorvastatin; Comorbidity; Drug Combinations; Female; Humans; Hypercholesterolemia; Hypertension; Male; Middle Aged; Perindopril; Prospective Studies | 2019 |
In black Africans with hypertension, amlodipine-based therapy vs perindopril-hydrochlorothiazide improved BP control.
Topics: Amlodipine; Antihypertensive Agents; Black People; Blood Pressure; Humans; Hydrochlorothiazide; Hypertension; Perindopril | 2019 |
Feasibility of 24-h central blood pressure monitoring: experience from multinational clinical trial assessing the efficacy of perindopril/indapamide/amlodipine.
Topics: Amlodipine; Antihypertensive Agents; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Drug Combinations; Feasibility Studies; Humans; Hypertension; Indapamide; Perindopril; Randomized Controlled Trials as Topic | 2019 |
Treatment with Free Triple Combination Therapy of Atorvastatin, Perindopril, Amlodipine in Hypertensive Patients: A Real-World Population Study in Italy.
Topics: Aged; Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Atorvastatin; Biomarkers; Blood Pressure; Calcium Channel Blockers; Databases, Factual; Drug Therapy, Combination; Dyslipidemias; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertension; Italy; Lipids; Male; Medication Adherence; Middle Aged; Perindopril; Retrospective Studies; Risk Factors; Time Factors; Treatment Outcome | 2019 |
[Antihypertensive Effect of Switching to a Fixed Perindopril/Amlodipine Combination in Patients Ineffectively Treated by Free Sartan-Containing Combinations. Results of the AVANGARD Study].
Topics: Amlodipine; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Blood Pressure; Drug Combinations; Humans; Hypertension; Perindopril; Russia | 2019 |
Comparative effectiveness of combination treatment for hypertension in black Africans.
Topics: Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Black People; Calcium Channel Blockers; Comparative Effectiveness Research; Controlled Clinical Trials as Topic; Drug Therapy, Combination; Humans; Hydrochlorothiazide; Hypertension; Perindopril | 2020 |
Importance of fixed-dose combinations in cardiovascular prevention: the possibility of treating two diagnoses with a single pill.
Topics: Amlodipine; Antihypertensive Agents; Atorvastatin; Blood Pressure; Cardiovascular Diseases; Drug Combinations; Humans; Hypertension; Perindopril | 2020 |
The impact of manual quality control review on the feasibility of central ambulatory blood pressure monitoring.
Topics: Amlodipine; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Feasibility Studies; Humans; Hypertension; Indapamide; Perindopril; Quality Control | 2020 |
Reply.
Topics: Amlodipine; Blood Pressure; Feasibility Studies; Indapamide; Perindopril | 2020 |
[Antihypertensive and Vasoprotective Effects of Combined Pharmacotherapy in Patients with Arterial Hypertension and Prediabetes].
Topics: Amlodipine; Antihypertensive Agents; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Drug Combinations; Humans; Hypertension; Indapamide; Perindopril; Prediabetic State | 2020 |
[Therapeutic approaches to the Rational Use of trip-le combination therapy with a fixed combination of amlodipine, indapamide and perindopril arginine (TRIPLE COMBINATION) in patients with hypertension who do not control blood pressure on conventional tre
Topics: Aged; Amlodipine; Antihypertensive Agents; Arginine; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Drug Combinations; Female; Humans; Hypertension; Indapamide; Male; Middle Aged; Perindopril; Quality of Life; Treatment Outcome | 2020 |
[Comorbidity of arterial hyperten-sion and tension-type headache].
Topics: Amlodipine; Antihypertensive Agents; Blood Pressure; Comorbidity; Drug Combinations; Humans; Hypertension; Indapamide; Perindopril; Tension-Type Headache | 2020 |
Determination of amlodipine, indapamide and perindopril in human plasma by a novel LC-MS/MS method: Application to a bioequivalence study.
Topics: Adult; Amlodipine; Antihypertensive Agents; Chromatography, High Pressure Liquid; Humans; Indapamide; Limit of Detection; Middle Aged; Perindopril; Specimen Handling; Tandem Mass Spectrometry; Therapeutic Equivalency | 2021 |
[Fixed combination atorvastatin-perindopril (Lipercosyl®) for substitution treatment of cardiovascular risk management].
Topics: Amlodipine; Antihypertensive Agents; Atorvastatin; Blood Pressure; Cardiovascular Diseases; Drug Combinations; Heart Disease Risk Factors; Humans; Hypertension; Perindopril; Risk Factors | 2021 |
[What do we Mean by "Ideal" Blood Pressure Control?]
Topics: Amlodipine; Antihypertensive Agents; Blood Pressure; Drug Combinations; Heart Failure; Humans; Hypertension; Myocardial Infarction; Perindopril | 2021 |
[Vasoprotective effects hypotensive therapy in patients with coronary heart disease combined with chronic kidney disease stage 2-3 after coronary stenting].
Topics: Amlodipine; Antihypertensive Agents; Blood Pressure; Coronary Disease; Drug Combinations; Humans; Hypertension; Perindopril; Pulse Wave Analysis; Renal Insufficiency, Chronic | 2021 |
Effectiveness of indapamide/amlodipine single-pill combination in patients with isolated systolic hypertension: post-hoc analysis of the ARBALET study.
Topics: Aged; Amlodipine; Antihypertensive Agents; Blood Pressure; Drug Combinations; Female; Humans; Hypertension; Indapamide; Male; Middle Aged; Perindopril; Treatment Outcome | 2022 |
Use of Perindopril Arginine/Indapamide/Amlodipine in the Management of Hypertension in Two Sub-Saharan African Island Countries of Madagascar and Mauritius.
Topics: Amlodipine; Antihypertensive Agents; Arginine; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Drug Combinations; Humans; Hypertension; Indapamide; Madagascar; Mauritius; Perindopril; Treatment Outcome | 2022 |
Analysis of Fixed-Dose Combination of Three Antihypertensive Drugs by a Green and Quality by Design Approach.
Topics: Amlodipine; Antihypertensive Agents; Chromatography, High Pressure Liquid; Indapamide; Perindopril | 2023 |
Impact of simultaneous management of hypertension and hypercholesterolemia with ACE inhibitors and statins on cardiovascular outcomes in the Brisighella Heart Study: A 8-year follow-up.
Topics: Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Atorvastatin; Blood Pressure; Calcium; Calcium Channel Blockers; Diabetes Mellitus, Type 2; Follow-Up Studies; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Hypertension; Perindopril | 2022 |
In Vitro Dissolution Profile of Antihypertensive Mixture: Comparison Between Multivariate Methods and Statistical and Graphical Representation of Different Univariate Spectrophotometric Data.
Topics: Amlodipine; Antihypertensive Agents; Drug Combinations; Indapamide; Perindopril; Solubility | 2023 |
Adherence to Triple Single-Pill Combination of Perindopril/Indapamide/Amlodipine: Findings from Real-World Analysis in Italy.
Topics: Adult; Amlodipine; Antihypertensive Agents; Blood Pressure; Drug Combinations; Humans; Hypertension; Indapamide; Leukemia, Myeloid, Acute; Medication Adherence; Perindopril; Retrospective Studies | 2023 |
Utilization of erythrosine B in spectrofluorimetric quenching analysis of amlodipine and perindopril in pharmaceutical and biological matrices.
Topics: Amlodipine; Erythrosine; Humans; Leukemia, Myeloid, Acute; Perindopril; Pharmaceutical Preparations; Spectrometry, Fluorescence | 2023 |
THE NITROSAMINE CONTAMINATION IN BETA BLOCKERS (BISOPROLOL/METOPROLOL), ACE INHIBITORS (LISINOPRIL/PERINDOPRIL), THIAZIDES DIURETICS (HCT), CALCIUM CHANNEL BLOCKERS (AMLODIPINE/FELODIPINE), SARTANS (CANDESARTAN) AND ТHE SUBSEQUENT SKIN CANCER DEVELOPMENT
Topics: Amlodipine; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Bisoprolol; Calcium; Calcium Channel Blockers; Diabetes Mellitus, Type 2; Felodipine; Humans; Lisinopril; Melanoma; Metoprolol; Nitrosamines; Perindopril; Prospective Studies; Skin Neoplasms; Sodium Chloride Symporter Inhibitors; Thiazides | 2023 |
In the prevention of dementia, the focus should be on early and consistent treatment of hypertension.
Topics: Amlodipine; Antihypertensive Agents; Blood Pressure; Dementia; Drug Combinations; Humans; Hypertension; Middle Aged; Perindopril | 2023 |
NITROSOGENESIS OF SKIN CANCER: THE NITROSAMINE CONTAMINATION IN THE CALCIUM CHANNEL BLOCKERS (AMLODIPINE), BETA BLOCKERS (BISOPROLOL), SARTANS (VALSARTAN/LOSARTAN), ACE INHIBITORS (PERINDOPRIL/ENALAPRIL), TRICYCLIC ANTIDEPRESSANTS (MELITRACEN), SSRIS (PAR
Topics: Amlodipine; Angiotensin II Type 1 Receptor Blockers; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antidepressive Agents, Tricyclic; Bisoprolol; Calcium Channel Blockers; Enalapril; Humans; Incidence; Losartan; Metformin; Paroxetine; Perindopril; Selective Serotonin Reuptake Inhibitors; Serotonin and Noradrenaline Reuptake Inhibitors; Skin Neoplasms; Valsartan; Venlafaxine Hydrochloride | 2023 |
A real-world analysis of outcomes and healthcare costs of patients on perindopril/indapamide/amlodipine single-pill vs. multiple-pill combination in Italy.
Topics: Adult; Amlodipine; Antihypertensive Agents; Drug Combinations; Health Care Costs; Humans; Hypertension; Indapamide; Leukemia, Myeloid, Acute; Medication Adherence; Perindopril; Retrospective Studies; State Medicine | 2024 |